← Open Payments lookup

DANIEL DULANEY: Open Payments

NPI 1538647417 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$772 in 40 payments from 11 companies in 2025. Trend: 2023 $129 · 2024 $157 · 2025 $772

Food & beverage: $772
CompanyPaymentsAmount
ABBVIE INC.20$351
Otsuka America Pharmaceutical, Inc.5$142
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$73
Takeda Pharmaceuticals U.S.A., Inc.3$46
Supernus Pharmaceuticals, Inc.2$31
Vanda Pharmaceuticals Inc.1$29
Axsome Therapeutics, Inc.1$27
Otsuka Pharmaceutical Development & Commercialization, Inc.1$22
Teva Pharmaceuticals USA, Inc.1$21
Lundbeck LLC1$16

Products named: VRAYLAR, REXULTI, CAPLYTA, TRINTELLIX, Qelbree, FANAPT, Auvelity, REJOYN.

Industry payments across PA — which companies pay providers there.